Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 14M | 16M |
| Cost of revenue | 2M | 475,000 |
| Research and development | 74M | 59M |
| Selling, general and administrative | 22M | 25M |
| Operating income | −84M | −89M |
| Pre-tax income | −78M | −79M |
| Income tax | 1M | −2M |
| Net income | −80M | −77M |
| Earnings per share | −1.28 | −1.32 |
| Earnings per share, diluted | −1.28 | −1.32 |
| Weighted average shares | 62M | 58M |
| Weighted average shares, diluted | 62M | 58M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6M | 15M | 9M | 11M | 13M | 19M | 12M | 25M |
| Short-term investments | 35M | 51M | 67M | 78M | 93M | 107M | 133M | 131M |
| Receivables | — | — | — | 3M | — | — | — | — |
| Current assets | 46M | 72M | 83M | 100M | 112M | 132M | 149M | 161M |
| Property, plant and equipment | 8M | 8M | 8M | 9M | 9M | 10M | 10M | 11M |
| Total assets | 64M | 92M | 106M | 123M | 136M | 157M | 195M | 208M |
| Current liabilities | 17M | 21M | 19M | 18M | 14M | 18M | 20M | 17M |
| Total liabilities | 33M | 38M | 37M | 36M | 33M | 36M | 42M | 39M |
| Equity | 31M | 53M | 69M | 88M | 103M | 121M | 154M | 170M |
| Shares outstanding | 63M | 63M | 62M | 62M | 62M | 60M | 59M | 59M |
| Shares issued | 63M | 63M | 62M | 62M | 62M | 60M | 59M | 59M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −64M | −58M |
| Depreciation and amortisation | 5M | 3M |
| Share-based compensation | 12M | 13M |
| Capital expenditure | 9,000 | 237,000 |
| Investing cash flow | 59M | 8M |
| Financing cash flow | 594,000 | 59M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator